The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The Greek Orthodox Archdiocese of America Center for Family Care announces the awarding of a generous grant from Lilly Endowment Inc. for the establishment of a new initiative On Behalf of All: Toward ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

LONDON -- Britain's new Labour Party government announced billions of dollars in investment in U.K. artificial intelligence, ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The conference is made possible by the $1.24 million grant Lee received from Lilly Endowment Inc. through its Compelling Preaching Initiative. The aim of the initiative is to foster and support ...